These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 10089087)
1. The anti-emetic efficacy of tropisetron plus dexamethasone in patients treated with high-dose chemotherapy and stem cell transplantation. Barbounis V; Koumakis G; Hatzichristou H; Vassilomanolakis M; Tsoussis S; Efremidis A Support Care Cancer; 1999 Mar; 7(2):79-83. PubMed ID: 10089087 [TBL] [Abstract][Full Text] [Related]
2. The anti-emetic efficacy and tolerability of tropisetron in patients conditioned with high-dose chemotherapy (with and without total body irradiation) prior to bone marrow transplantation. Or R; Drakos P; Nagler A; Naparstek E; Kapelushnik J; Cass Y Support Care Cancer; 1994 Jul; 2(4):245-8. PubMed ID: 8087443 [TBL] [Abstract][Full Text] [Related]
3. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience. Sorbe BG Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123 [TBL] [Abstract][Full Text] [Related]
4. Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents. Bruntsch U; Drechsler S; Eggert J; Gosse H; Ukena D; Imhoff W; Faerber L Semin Oncol; 1994 Oct; 21(5 Suppl 9):7-11. PubMed ID: 9113120 [TBL] [Abstract][Full Text] [Related]
5. A study evaluating the efficacy and tolerability of tropisetron in combination with dexamethasone in the prevention of delayed platinum-induced nausea and emesis. Sorbe BG; Berglind AM; Andersson H; Boman K; Högberg T; Hallgren M; Schmidt M Cancer; 1998 Sep; 83(5):1022-32. PubMed ID: 9731907 [TBL] [Abstract][Full Text] [Related]
6. Navoban (tropisetron, ICS 205-930) and dexamethasone combination in the prevention of vomiting for patients receiving preconditioning high-dose chemotherapy before marrow transplantation. Yen CC; Hsieh RK; Chiou TJ; Liu JH; Fang FS; Wang WS; Tung SL; Tzeng CH; Chen PM Jpn J Clin Oncol; 1998 Feb; 28(2):129-33. PubMed ID: 9544829 [TBL] [Abstract][Full Text] [Related]
7. Prospective randomized comparison of tropisetron with and without dexamethasone against high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. Malik I; Moid I; Khan Z; Hussain M Am J Clin Oncol; 1999 Apr; 22(2):126-30. PubMed ID: 10199444 [TBL] [Abstract][Full Text] [Related]
8. [Tropisetron in attenuation of nausea and vomiting in patients undergoing high-dose chemo-radiotherapy supported by autologous peripheral blood stem cell transplantation]. He XH; Shi YK; Yang JL; Zhang CG; Liu P; Zhou AP; Zhou SY; Ai B Ai Zheng; 2004 Apr; 23(4):456-60. PubMed ID: 15087039 [TBL] [Abstract][Full Text] [Related]
9. Ondansetron and tropisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy. Stiakaki E; Savvas S; Lydaki E; Bolonaki I; Kouvidi E; Dimitriou H; Kambourakis A; Kalmanti M Pediatr Hematol Oncol; 1999; 16(2):101-8. PubMed ID: 10100270 [TBL] [Abstract][Full Text] [Related]
10. Antiemetic efficacy of three serotonin antagonists during high-dose chemotherapy and autologous stem cell transplantation in malignant lymphoma. Slabý J; Trnený M; Procházka B; Klener P Neoplasma; 2000; 47(5):319-22. PubMed ID: 11130251 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of tropisetron and dexamethasone in the control of nausea and vomiting induced by cisplatin. Schmidt M; Sorbe B; Högberg T; Himmelmann A; Räisänen I; Stockmeyer M; de Bruijn KM Ann Oncol; 1993; 4 Suppl 3():31-4. PubMed ID: 8363997 [TBL] [Abstract][Full Text] [Related]
12. Antiemetic efficacy of granisetron plus dexamethasone in bone marrow transplant patients receiving chemotherapy and total body irradiation. Abbott B; Ippoliti C; Bruton J; Neumann J; Whaley R; Champlin R Bone Marrow Transplant; 1999 Feb; 23(3):265-9. PubMed ID: 10084258 [TBL] [Abstract][Full Text] [Related]
13. Tropisetron: an update of its use in the prevention of chemotherapy-induced nausea and vomiting. Simpson K; Spencer CM; McClellan KJ Drugs; 2000 Jun; 59(6):1297-315. PubMed ID: 10882164 [TBL] [Abstract][Full Text] [Related]
14. A phase II study of ondansetron as antiemetic prophylaxis in patients receiving high-dose polychemotherapy and stem cell transplantation. Barbounis V; Koumakis G; Vassilomanolakis M; Hatzichristou H; Tsousis S; Efremidis AP Support Care Cancer; 1995 Sep; 3(5):301-6. PubMed ID: 8520876 [TBL] [Abstract][Full Text] [Related]
15. Tropisetron in the prevention of acute nausea and vomiting in patients treated with high dose epirubicin. Nicolaides C; Giannakakis T; Skarlos D; Athanassiadis A; Fountzilas G; Damigos D; Pavlidis N J Exp Clin Cancer Res; 1998 Mar; 17(1):71-5. PubMed ID: 9646236 [TBL] [Abstract][Full Text] [Related]
16. Tropisetron alone or in combination with dexamethasone for the prevention and treatment of emesis induced by non-cisplatin chemotherapy: a randomized trial. Adams M; Soukop M; Barley V; Yosef H; Anderson H; Boesen E; Trask CW; Rüfenacht E; de Bruijn KM Anticancer Drugs; 1995 Aug; 6(4):514-21. PubMed ID: 7579555 [TBL] [Abstract][Full Text] [Related]
17. Optimal combination therapy with tropisetron in 445 patients with incomplete control of chemotherapy-induced nausea and vomiting. Hulstaert F; Van Belle S; Bleiberg H; Canon JL; Dewitte M; Buyse M; De Keyser P; Westelinck KJ J Clin Oncol; 1994 Nov; 12(11):2439-46. PubMed ID: 7964961 [TBL] [Abstract][Full Text] [Related]
18. Infusion of palonosetron plus dexamethasone for the prevention of chemotherapy-induced nausea and vomiting. Hajdenberg J; Grote T; Yee L; Arevalo-Araujo R; Latimer LA J Support Oncol; 2006 Oct; 4(9):467-71. PubMed ID: 17080735 [TBL] [Abstract][Full Text] [Related]
19. Tropisetron in the prevention of acute and delayed nausea and vomiting over six courses of emetogenic chemotherapy. Bleiberg H; Hulstaert F; Buyse M; De Keyser P Anticancer Drugs; 1998 Oct; 9(9):773-7. PubMed ID: 9840722 [TBL] [Abstract][Full Text] [Related]
20. Combination therapy for chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy: palonosetron, dexamethasone, and aprepitant. Grote T; Hajdenberg J; Cartmell A; Ferguson S; Ginkel A; Charu V J Support Oncol; 2006 Sep; 4(8):403-8. PubMed ID: 17004515 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]